Navigation Links
Growth in the global carbon budget
Date:9/24/2008

Today the new Global Carbon Budget was launched simultaneously by Global Carbon Project co-chair Michael Raupach in France at the Paris Observatory, and in the USA at Capitol Hill, Washington by GCP Executive Director Pep Canadell.

The Global Carbon Project posted the most recent figures for the worlds' carbon budget, a key to understanding the balance of carbon added to the atmosphere, the underpinning of human induced climate change. Despite the increasing international sense of urgency, the growth rate of emissions continued to speed up, bringing the atmospheric CO2 concentration to 383 parts per million (ppm) in 2007.

Anthropogenic CO2 emissions have been growing about four times faster since 2000 than during the previous decade, despite efforts to curb emissions in a number of Kyoto Protocol signatory countries. Emissions from the combustion of fossil fuel and land use change reached 10 billion tones of carbon in 2007. Natural CO2 sinks are growing but slower than the atmospheric CO2 growth, which has been increasing at 2 ppm since 2000 or 33% faster than the previous 20 years.

Dr. Pep Canadell, executive director of the Global Carbon Project said "This new update of the carbon budget shows the acceleration of both CO2 emissions and atmospheric accumulation are unprecedented and most astonishing during a decade of intense international developments to address climate change."

Emissions growth for 2000-2007 was above even the most fossil fuel intensive scenario of the Intergovernmental Panel on Climate Change (SRES-IPCC). While the developing nations of China and India continue to increase emissions, China has improved the carbon intensity of their economy since 2005, based on data from the National Energy Administration in China.

Decreasing forest cover, almost exclusively from deforestation in tropical countries, was responsible for an estimated 1.5 billion t
'/>"/>

Contact: Pep Canadell
Pep.Canadell@csiro.au
61-407-068-930
Global Carbon Project
Source:Eurekalert

Page: 1 2

Related biology news :

1. Circadian clock controls plant growth hormone
2. Population movements and money remittances spur forest regrowth
3. Paracetamol, one of most used analgesics, could slow down bone growth
4. Targeting nerve growth factor may cure liver cancer
5. Study shows vitamin C is essential for plant growth
6. Study reveals a key to blood vessel growth and possible drug target
7. Brain cell growth diminishes long before old age strikes, animal study shows
8. Sea cucumbers fast track organ regrowth by healing their wounds
9. Pourquie Lab demonstrates role of growth factor in vertebrae formation
10. Cold Spring Harbor Protocols highlights a method that captures cell growth and activity
11. FIJI Water announces sustainable growth initiative with commitment to help mitigate climate change

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...ists are revealing the genetic instructions inside... maize, has one of the most complex sequences of D...ison genomicist David Schwartz, who was one of mor...Science . , "The maize genome is a true maze fu...oubled would-be sequencers for years," says Schwar...
(Date:11/19/2009)... 1 = more than 2: The offspring of two inbred stra...Characterizing the gene-level variability that lea...d vigor, could boost our ability to custom-tailor ...ntent for human consumption or high glucose conten...released DNA sequence of the common corn strain B7...
(Date:11/19/2009)...etic diversity in maize, also known as corn, resea...gene map that should pave the way to significant i...ood, fuel, animal feed and fiber around the world.... as a haplotype map, charts genetic diversity and ... of maize. The research team, led by U.S. Departme...
Breaking Biology News(10 mins):Sweet corn story begins in UW-Madison lab 2Sweet corn story begins in UW-Madison lab 3U of M plant scientist uncovers clues to yield-boosting quirks of corn genome 2University Medical Pharmaceuticals Selects Jeffrey Ten as Senior Vice President International Sales 5593 1University Medical Pharmaceuticals Selects Jeffrey Ten as Senior Vice President International Sales 5593 2University Medical Pharmaceuticals Selects Jeffrey Ten as Senior Vice President International Sales 5593 3BrainCells Inc Broadens Scientific Advisory Board Adding Drs Edward Scolnick and David Holtzman 5590 1BrainCells Inc Broadens Scientific Advisory Board Adding Drs Edward Scolnick and David Holtzman 5590 2BrainCells Inc Broadens Scientific Advisory Board Adding Drs Edward Scolnick and David Holtzman 5590 3Enhanced Food Safety and Systems Interoperability the Themes of Food Traceability Interoperability Summit 2010 5587 1Enhanced Food Safety and Systems Interoperability the Themes of Food Traceability Interoperability Summit 2010 5587 2
...ns when no medical necessity exists - Florida, Ne...ington, Florida increase most , The number of pre...sarean section (C-section) rose by 36.6 percent fr...ay by HealthGrades, the leading provider of indepe...e variation from state to state in the rate of the...
...al waste, placental tissue could feasibly provide ...l to treat diseases and regenerate tissues as thei...cells, suggests a University of Pittsburgh study t...able now as an early online publication in Stem Ce...mnion, or the outer membrane of the amniotic sac, ...
... the risk of mother-to-child transmission of hepat...ublished in the December 1 issue of The Journal of... study found that infant girls are twice as likely...ide new information with which to counsel pregnant...new studies expand upon preliminary data from smal...
Other Biology News:'Patient-choice' C-section rate rises 36%: HealthGrades study 2'Patient-choice' C-section rate rises 36%: HealthGrades study 3Discarded placentas deliver researchers promising cells similar to embryonic stem cells 2Discarded placentas deliver researchers promising cells similar to embryonic stem cells 3Discarded placentas deliver researchers promising cells similar to embryonic stem cells 4Studies clarify risk factors for mother-to-child transmission of hepatitis C virus 2
(Date:11/18/2009)... -- Marrone Bio Innovations (MBI), a leader in the...ffective and environmentally responsible pest mana...an IC20 company by the Investors, Circle, the Unit...ting group. ,, Companies named to the IC20 exce...all stakeholders, including investors, the environ...
(Date:11/18/2009)...ind explosive materials and persons who have been ...tional Institute of Standards and Technology (NIST...curity, has developed a new certified reference ma...ace Particulate Explosives. Compatible with field ...ful in calibrating, testing and developing standar...
(Date:11/18/2009)...e developing new sensors to detect chemical agents...ainst the threat of terrorist attacks. , The dev...idual or crime scene to gather a sample which is t...ect the presence of chemicals within seconds. This... response to terrorist threats. , The scanning ...
(Date:11/18/2009)...alysis combined with Bio-Rad,s Biotechnology E...ovide state-of-the-art solutions to biotechnology ...wire/ -- Vernier Software & Technology, a prov...nd software and Bio-Rad Laboratories, Inc., a mult...ence research and clinical diagnostics products th...
Breaking Biology Technology:Marrone Bio Innovations Named an IC20 Company 2New NIST trace explosives standard slated for homeland security duty 2New technology detects chemical weapons in seconds 2Vernier and Bio-Rad to Offer Enhanced Solutions for Biotechnology Education 2
...ce to $0.64 - $0.67 from Prior Range of ... EPS Guidance of $0.90 - $1.10 for 2009 and $1.50 ...PITTSBURGH, Oct. 30 Mylan Inc. (NYSE: MYL ),toda...d nine months ended,Sept. 30, 2008., Financial Hi....52 for the three and nine,months ended Sept. 30, ...
...Inc. (Nasdaq:,INSM), a developer of follow-on biol...ts for the third quarter and nine-months ended Sep... Follow-on Biologics Program -- Received app... Healthcare products Regulatory Agency to init...pany,s second follow-on biologic ("FOB") ...
...oratories Inc., a,specialty pharmaceutical and dia...nd Trademark Office (USPTO) has issued two separat...) Thiopurine Metabolites, a,diagnostic test that e...iopurines to reach and maintain desired therapeuti...he claims in U.S. Patent Nos. 7,425,546 and,7,429,...
Other Biology Technology:Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008 2Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008 3Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008 4Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008 5Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008 6Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008 7Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008 8Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008 9Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008 10Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008 11Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008 12Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008 13Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008 14Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008 2Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008 3Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008 4Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008 5Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008 6Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008 7Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008 8Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008 9Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008 10Prometheus Strengthens Intellectual Property Portfolio with Newly Issued Patents for Thiopurine Metabolite Testing 2
...Kit contains all reagents necessary to efficiently...tic lineage, as determined by staining for mineral...essary reagents and a protocol for quantifying ost...uct is useful for studying the effects of growth f...
...arch: Developed for a wide range of bioanalytical ... in Luminescence Spectroscopy • Automated acc...ic gratings for reduced stray light • Versati...non lamp reduces photo bleaching • Large conv...
...tent-pending Formula Predictor software takes adva... pattern verification, and unique fragment-ion fil...ect formula for unknown components. Traditional ...ss spec data often depend on very high mass accura...
PerkinElmer Spectrum Beer's Law QUANT Quantitative Software, Floppy Disk from PerkinElmer
Biology Products: